Department of Surgery, Dona-A University Hospital, Seo-gu, Busan, Republic of Korea.
Division of Vascular Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Songpa-gu, Seoul, Republic of Korea.
PLoS One. 2021 Dec 2;16(12):e0260690. doi: 10.1371/journal.pone.0260690. eCollection 2021.
This study aimed to compare the quality of life and cost effectiveness between endovascular aneurysm repair (EVAR) and open surgical repair (OSR) in young patients with abdominal aortic aneurysm (AAA).
This was a single-center, observational, and retrospective study.
A retrospective analysis was conducted of patients with AAA, who were <70 years old and underwent EVAR or OSR between January 2012 and October 2016. Only patients with aortic morphology that was suitable for EVAR were enrolled. Data on the complication rates, medical expenses, and expected quality-adjusted life years (QALYs) were collected, and the cost per QALY at three years was compared.
Among 90 patients with aortic morphology who were eligible for EVAR, 37 and 53 patients underwent EVAR and OSR, respectively. No significant differences were observed in perioperative cardiovascular events and death between the two groups. However, during the follow-up period, patients undergoing OSR showed a significantly lower complication rate (hazard ratio [HR] = 0.11; P = .021). From the three-year cost-effectiveness analysis, the total sum of costs was significantly lower in the OSR group (P < .001) than that in the EVAR group, and the number of QALYs was superior in the OSR group (P = .013). The cost per QALY at three years was significantly lower in the OSR group than that in the EVAR group (mean: $4038 vs. $10 137; respectively; P < .001).
OSR had lower complication rates and better cost-effectiveness than EVAR Among young patients with feasible aortic anatomy.
本研究旨在比较腔内修复术(EVAR)和开放手术修复(OSR)治疗年轻腹主动脉瘤(AAA)患者的生活质量和成本效益。
这是一项单中心、观察性、回顾性研究。
对 2012 年 1 月至 2016 年 10 月期间接受 EVAR 或 OSR 治疗且年龄<70 岁的 AAA 患者进行回顾性分析。仅纳入适合 EVAR 的主动脉形态患者。收集并发症发生率、医疗费用和预期质量调整生命年(QALY)的数据,并比较三年每 QALY 的成本。
在 90 名适合 EVAR 的主动脉形态患者中,37 名患者接受 EVAR,53 名患者接受 OSR。两组患者围手术期心血管事件和死亡无显著差异。然而,在随访期间,OSR 组的并发症发生率明显较低(风险比 [HR] = 0.11;P =.021)。从三年成本效益分析来看,OSR 组的总成本显著低于 EVAR 组(P <.001),OSR 组的 QALY 数量也更优(P =.013)。OSR 组三年每 QALY 的成本明显低于 EVAR 组(均值:4038 美元对 10137 美元;P <.001)。
对于具有可行主动脉解剖结构的年轻患者,OSR 的并发症发生率较低,成本效益较好。